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INTRODUCTION
Cardiovascular disease (CVD) is a broad term covering disorders of the heart and blood vessels. Examples include hypertension, angina, heart attack, stroke, and heart failure [1] . CVDs accounts for the highest number of deaths worldwide [2] . There is evidence that as many as 50% of prescribed CVD drugs worldwide are not taken by patients as recommended. Medication adherence can be assessed by indirect methods (e.g. questionnaire) or direct methods (concentration of drugs or metabolites in a biological fluid (such as urine or blood). However, no consensus has been reached on a gold standard for routine clinical practice [3] . The 8-item Morisky Medication Adherence Scale (8-MMAS), provides a single qualitative ternary metric to assess adherence (low, medium, or high) depending on the total score. Conventional direct methods require large blood volumes (0.5 -10 mL) [1] . Dried blood spot (DBS) sampling is an alternative to conventional methods [4] . It is less invasive, typically involving the collection of just a few drops of blood from a finger or heel prick onto a filter paper [1] . The aim of this research was to assess patients' non-adherence to treatment with atenolol, atorvastatin, bisoprolol, diltiazem, lisinopril, losartan, simvastatin and valsartan by 8-MMAS and determination of the target medications in DBS from the same patients and to compare the results obtained from the two approaches
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MATERIALS AND METHODS
69 patients were recruited at the Alsaeder Teaching Hospital in Iraq during routine clinical visits. Following consent, patients were invited to complete an Arabic version of (8-MMAS) questionnaire and to provide a finger-prick blood spots samples on DBS cards. Drugs concentration in DBS was determined by liquid chromatography-high resolution mass spectrometry (LC-HRMS) [5] . Patients were categorized as non-adherent when one or more of their prescribed cardiovascular medications were outside the range of (0.05) Cmax to Cmax.
RESULTS AND DISCUSSION
8-MMAS showed that 54 participants (78.3%) were adherent (30 males and 24 females), 15 participants (21.7%) were non-adherent ( 11 males and 4 females).
However, adherence assessment by DBS showed that 35 patients (50.7%) were adherent to medications (21 males and 14 females) and 34 patients (49.3%) were non-adherent (20 males and 14 females). Both approaches showed no significant relationship between medication non-adherence and gender. The negative correlation between adherence and the number of medications was seen in both approaches. DBS analysis showed that adherence to medication was not uniform (Fig 1) . 44 participants (63.8%) showed agreement and 25 (36.2%) showed disagreement. 22 patients were classified as adherent according to 8-MMAS but they were non-adherent according to their blood concentration. This difference may be due to prescribing errors, substandard medications, individual pharmacokinetic variability, or drug interactions. The other 3 patients were non-adherent by the 8-MMAS but were defined as adherent according to DBS analysis. The agreement between the two approached was weak (Kappa = 0.269, p-value ˂ 0.05).
The answers to the Morisky questions with respect to non-adherence were:
• 75% cited inconvenience with medications • 70.7% gave no reasons • 66.7% cited medication side effects • 58.3% cited poor understanding of treatment • 58.3% cited travel problem • 41.7% cited simple forgetfulness
Fig. 1. Comparison of non-adherence among the Iraq patient group for each of the target cardiovascular drugs by DBS analysis and 8-MMAS
CONCLUSIONS
The Morisky 8-MMAS and the DBS sampling approach both indicated levels of non-adherence. Poor agreement between the two approaches was seen. The DBS derived data provided drug specific information about patient medication taking behaviour. The results from the DBS sampling indicated that non-adherence was not uniform towards the different medications in the sample medical regimens tested.
